Capricor Therapeutics is a clinical-stage biopharmaceutical company specializing in cell therapy and regenerative medicine, headquartered in San Diego, California. Founded in 2005, the company develops investigational cell-based treatments for cardiovascular disease, heart failure, and other serious medical conditions. Capricor's therapeutic approach centers on cellular and tissue-based platforms designed to harness the body's regenerative potential. As a private company operating in the competitive clinical-stage biotech space, Capricor is focused on advancing its pipeline of cell therapy programs through clinical development. The company represents the emerging wave of regenerative medicine-focused biotechnology, where cell-based approaches are being explored as potentially transformative treatments for diseases that currently lack adequate therapeutic options.
40 open now, 40 first appeared in the last 30d.